Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 10.6c
Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009
Recipients with Intestine Transplants
No Steroids Used for Maintenance
Steroids Used for Maintenance
N
%
N
%
Functioning Graft with Immunosuppression Info at Discharge
211
100.0%
576
100.0%
Induction Drugs
Atgam/NRATG/NRATS
2
0.9%
4
0.7%
OKT3
3
1.4%
24
4.2%
Thymoglobulin
93
44.1%
106
18.4%
Zenapax
6
2.8%
69
12.0%
Simulect
14
2.4%
Campath
73
34.6%
63
10.9%
Rituximab
74
35.1%
9
1.6%
No Induction Drug Reported
38
18.0%
326
56.6%
Source: OPTN/SRTR Data as of October 1, 2010.
Includes patients with a functioning graft at discharge.
Steroids used for induction are not counted.
Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.